Abstract
Purpose/Background/Objectives
Obesity is associated with increased risk factors for cardiovascular disease (CVD). Leptin-deficient mice (ob/ob) are widely employed to investigate obesity. This study is aimed at providing a micro-ultrasound (mUS) longitudinal evaluation of the ob/ob mouse in terms of cardiovascular effects, consequences for renal microcirculation and liver fat accumulation.
Methods
Sixteen wild-type (wt) and eleven ob/ob male mice were studied at 8 (T0) and 25 (T1) weeks of age with a mUS system (Vevo2100). Cardiac output (CO), ejection fraction (EF), stroke volume (SV), fractional shortening (FS) and E/A ratio were measured from cardiac images. Mean diameter (Dmabd, Dmcar), relative distension (relDabd, relDcar) and pulse wave velocity (PWVabd, PWVcar) were obtained for both abdominal aorta and common carotid. Renal resistivity and pulsatility index (RI, PI) were assessed. The ratio between grey-levels related to liver and kidney (Steato-Score) was used as index of hepatic steatosis.
Results: At T0, ob/ob mice showed reduced SV, EF, CO and relDabd values and increased LVmass, PWVabd, RI, PI and Steato-score. Similar results for SV, EF, CO, RI, PI and Steato-Score were found at T1; furthermore, obese mice showed reduced Dmabd and Dmcar measurements in comparison with lean controls. The longitudinal analysis showed an increase in LVmass and Dmabd and a reduction of FS, EF, CO, relDabd and relDcar for wt animals and no differences for the ob/ob one.
Conclusions
ob/ob mice presented a premature cardiac dysfunction without a further age-related deterioration and a reduction in the abdominal aorta and carotid artery mean diameter in adult age.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 CNR, Institute of Clinical Physiology, Pisa, Italy (GRID:grid.418529.3) (ISNI:0000 0004 1756 390X); Scuola Superiore Sant’Anna, Institute of Life Sciences, Pisa, Italy (GRID:grid.263145.7) (ISNI:0000 0004 1762 600X)
2 CNR, Institute of Clinical Physiology, Pisa, Italy (GRID:grid.418529.3) (ISNI:0000 0004 1756 390X)
3 University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729)
4 University of Antwerp, Department of Pharmaceutical Sciences, Antwerp, Belgium (GRID:grid.5284.b) (ISNI:0000 0001 0790 3681)





